Nifty
Sensex
:
:
17331.80
58222.10
57.50 (0.33%)
156.63 (0.27%)

Pharmaceuticals & Drugs - Global

Rating :
37/99

BSE: 532300 | NSE: WOCKPHARMA

247.50
06-Oct-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 247.85
  • 252.25
  • 246.30
  • 245.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  453042
  •  1126.94
  •  492.54
  •  201.50

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,569.81
  • N/A
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,025.81
  • N/A
  • 0.95

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 65.75%
  • 2.00%
  • 25.97%
  • FII
  • DII
  • Others
  • 2.82%
  • 0.03%
  • 3.43%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -5.37
  • -3.88
  • -0.96

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -17.58
  • 176.92
  • 4.15

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -16.70
  • 52.19

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.29
  • 1.65
  • 1.29

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 57.06
  • 53.82
  • 37.26

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Net Sales
595.00
860.00
-30.81%
655.00
632.00
3.64%
853.89
764.02
11.76%
862.00
714.05
20.72%
Expenses
611.00
752.00
-18.75%
688.00
712.00
-3.37%
742.44
708.23
4.83%
766.17
697.35
9.87%
EBITDA
-16.00
108.00
-
-33.00
-80.00
-
111.45
55.79
99.77%
95.83
16.70
473.83%
EBIDTM
-2.69%
12.56%
-5.04%
-12.66%
13.05%
7.30%
11.12%
2.34%
Other Income
57.00
14.00
307.14%
14.00
22.00
-36.36%
2.05
103.13
-98.01%
5.20
16.24
-67.98%
Interest
73.00
64.00
14.06%
86.00
55.00
56.36%
80.08
59.85
33.80%
69.06
60.90
13.40%
Depreciation
64.00
64.00
0.00%
59.00
65.00
-9.23%
61.98
67.88
-8.69%
61.21
57.15
7.10%
PBT
-96.00
-6.00
-
-347.00
-178.00
-
-28.56
31.19
-
-29.24
-85.11
-
Tax
-21.00
1.00
-
-36.00
-71.00
-
-30.33
-1.21
-
-66.41
-88.40
-
PAT
-75.00
-7.00
-
-311.00
-107.00
-
1.77
32.40
-94.54%
37.17
3.29
1,029.79%
PATM
-12.61%
-0.81%
-47.48%
-16.93%
0.21%
4.24%
4.31%
0.46%
EPS
-4.65
-1.09
-
-17.92
-7.79
-
-0.56
1.27
-
2.79
0.30
830.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
2,965.89
3,230.00
2,708.00
3,325.15
4,158.38
3,936.90
4,014.61
4,453.22
4,481.54
4,830.36
5,609.42
Net Sales Growth
-0.14%
19.28%
-18.56%
-20.04%
5.63%
-1.94%
-9.85%
-0.63%
-7.22%
-13.89%
 
Cost Of Goods Sold
1,170.60
1,267.00
1,135.00
1,203.45
1,636.31
1,797.53
1,662.07
1,613.68
1,487.48
1,806.25
1,747.56
Gross Profit
1,795.29
1,963.00
1,573.00
2,121.70
2,522.07
2,139.37
2,352.54
2,839.54
2,994.06
3,024.11
3,861.86
GP Margin
60.53%
60.77%
58.09%
63.81%
60.65%
54.34%
58.60%
63.76%
66.81%
62.61%
68.85%
Total Expenditure
2,807.61
2,932.00
2,771.00
3,082.03
4,050.63
3,935.07
3,988.39
3,958.98
3,772.14
3,804.65
3,549.74
Power & Fuel Cost
-
98.00
82.00
85.41
93.30
77.80
110.10
113.99
101.40
92.17
97.08
% Of Sales
-
3.03%
3.03%
2.57%
2.24%
1.98%
2.74%
2.56%
2.26%
1.91%
1.73%
Employee Cost
-
749.00
763.00
743.33
800.38
937.06
966.51
950.77
868.87
768.63
655.90
% Of Sales
-
23.19%
28.18%
22.35%
19.25%
23.80%
24.07%
21.35%
19.39%
15.91%
11.69%
Manufacturing Exp.
-
169.00
145.00
120.90
153.76
135.27
179.40
228.07
236.03
240.85
180.06
% Of Sales
-
5.23%
5.35%
3.64%
3.70%
3.44%
4.47%
5.12%
5.27%
4.99%
3.21%
General & Admin Exp.
-
224.00
251.00
186.55
380.13
476.66
504.43
405.85
320.92
352.19
248.28
% Of Sales
-
6.93%
9.27%
5.61%
9.14%
12.11%
12.56%
9.11%
7.16%
7.29%
4.43%
Selling & Distn. Exp.
-
180.00
132.00
141.18
176.22
208.89
205.30
241.11
261.55
292.98
291.74
% Of Sales
-
5.57%
4.87%
4.25%
4.24%
5.31%
5.11%
5.41%
5.84%
6.07%
5.20%
Miscellaneous Exp.
-
245.00
263.00
601.21
810.53
301.86
360.58
405.51
495.89
251.58
291.74
% Of Sales
-
7.59%
9.71%
18.08%
19.49%
7.67%
8.98%
9.11%
11.07%
5.21%
5.87%
EBITDA
158.28
298.00
-63.00
243.12
107.75
1.83
26.22
494.24
709.40
1,025.71
2,059.68
EBITDA Margin
5.34%
9.23%
-2.33%
7.31%
2.59%
0.05%
0.65%
11.10%
15.83%
21.23%
36.72%
Other Income
78.25
20.00
132.00
60.08
21.02
120.23
100.83
66.10
66.55
38.40
54.00
Interest
308.14
299.00
249.00
275.74
265.14
255.49
225.27
128.96
55.21
83.35
215.37
Depreciation
246.19
247.00
246.00
224.14
163.95
149.53
148.93
141.91
145.40
139.92
122.14
PBT
-500.80
-228.00
-426.00
-196.68
-300.32
-282.96
-247.15
289.47
575.34
840.84
1,776.17
Tax
-153.74
-132.00
-271.00
-153.29
-83.66
25.70
-21.11
37.88
162.65
47.88
258.21
Tax Rate
30.70%
32.12%
47.71%
77.94%
27.86%
-4.01%
8.54%
13.09%
28.27%
5.38%
14.05%
PAT
-347.06
-244.00
-299.00
-69.22
-194.53
-608.30
-195.72
250.08
404.91
840.72
1,579.48
PAT before Minority Interest
-298.25
-279.00
-297.00
-43.39
-216.66
-666.85
-226.04
251.59
412.69
842.79
1,579.48
Minority Interest
48.81
35.00
-2.00
-25.83
22.13
58.55
30.32
-1.51
-7.78
-2.07
0.00
PAT Margin
-11.70%
-7.55%
-11.04%
-2.08%
-4.68%
-15.45%
-4.88%
5.62%
9.04%
17.40%
28.16%
PAT Growth
0.00%
-
-
-
-
-
-
-38.24%
-51.84%
-46.77%
 
EPS
-24.08
-16.93
-20.75
-4.80
-13.50
-42.21
-13.58
17.35
28.10
58.34
109.61

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
3,849.00
3,376.00
2,671.67
2,674.80
2,852.15
3,336.71
3,775.12
3,715.35
3,581.47
2,704.18
Share Capital
72.00
55.00
55.37
55.34
55.32
55.27
55.25
353.59
353.43
353.34
Total Reserves
3,759.00
3,293.00
2,586.33
2,587.19
2,760.11
3,244.43
3,691.22
3,315.65
3,182.73
2,319.30
Non-Current Liabilities
261.00
496.00
1,194.85
1,702.75
2,088.89
3,151.38
1,893.49
1,872.46
1,161.18
1,520.80
Secured Loans
260.00
500.00
1,237.44
1,653.25
2,167.84
2,887.11
1,647.34
1,180.25
1,096.27
1,467.51
Unsecured Loans
95.00
3.00
3.46
238.22
5.27
303.16
273.26
4.59
6.03
7.64
Long Term Provisions
32.00
84.00
45.60
53.48
64.89
94.23
70.74
635.05
51.98
69.85
Current Liabilities
3,207.00
3,121.00
3,497.18
2,863.66
2,691.71
1,978.81
1,841.85
1,772.97
1,743.20
1,773.48
Trade Payables
921.00
696.00
895.27
840.24
601.78
533.81
637.69
552.56
557.79
634.15
Other Current Liabilities
1,197.00
1,230.00
1,579.80
1,353.09
1,548.13
690.13
621.23
844.44
947.70
789.96
Short Term Borrowings
1,034.00
1,066.00
903.86
561.71
437.09
662.80
550.03
348.28
210.20
182.00
Short Term Provisions
55.00
129.00
118.25
108.62
104.71
92.07
32.90
27.69
27.51
167.37
Total Liabilities
7,670.00
7,376.00
7,749.49
7,571.04
7,978.48
8,848.84
7,975.79
7,504.73
6,622.02
5,998.46
Net Block
3,462.00
3,343.00
3,502.29
3,057.93
2,887.96
2,772.55
2,808.70
2,122.74
2,294.63
1,989.60
Gross Block
6,019.00
5,656.00
6,703.28
6,112.89
5,772.29
5,456.40
4,377.01
4,552.96
4,642.81
4,295.75
Accumulated Depreciation
2,557.00
2,313.00
3,200.99
3,054.96
2,884.33
2,683.85
1,568.31
2,430.22
2,348.18
1,684.94
Non Current Assets
5,081.00
4,951.00
5,319.66
4,756.39
4,598.88
4,313.57
4,023.94
3,983.17
3,266.10
2,671.53
Capital Work in Progress
1,342.00
1,379.00
1,584.53
1,445.48
1,432.57
1,243.95
1,036.05
1,007.30
707.53
490.94
Non Current Investment
0.00
0.00
0.45
0.45
0.45
0.45
0.45
2.62
2.62
2.63
Long Term Loans & Adv.
259.00
228.00
230.63
252.37
277.90
296.62
178.74
845.68
235.86
183.35
Other Non Current Assets
18.00
1.00
1.76
0.16
0.00
0.00
0.00
4.83
25.46
5.01
Current Assets
2,589.00
2,425.00
2,429.83
2,814.65
3,379.60
4,535.27
3,951.85
3,521.56
3,355.92
3,326.93
Current Investments
0.00
0.00
0.00
0.00
213.25
562.27
0.00
338.72
573.98
0.00
Inventories
769.00
799.00
689.83
819.36
855.71
1,107.95
1,102.16
1,020.78
992.89
1,058.83
Sundry Debtors
918.00
918.00
1,242.69
1,273.90
962.45
1,034.45
1,111.42
741.43
481.04
958.46
Cash & Bank
406.00
292.00
268.46
448.65
1,082.25
1,603.61
1,478.11
1,234.55
1,125.80
1,096.06
Other Current Assets
496.00
144.00
56.64
20.18
265.94
226.99
260.16
186.08
182.21
213.58
Short Term Loans & Adv.
352.00
272.00
172.21
252.56
257.63
197.75
260.16
186.08
182.21
213.58
Net Current Assets
-618.00
-696.00
-1,067.35
-49.01
687.89
2,556.46
2,110.00
1,748.59
1,612.72
1,553.45
Total Assets
7,670.00
7,376.00
7,749.49
7,571.04
7,978.48
8,848.84
7,975.79
7,504.73
6,622.02
5,998.46

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
413.00
-287.00
648.96
183.32
68.44
-269.47
71.61
354.96
1,476.29
1,532.40
PBT
-411.00
916.00
-196.68
-300.32
-641.15
-247.15
357.01
575.34
890.67
1,860.20
Adjustment
554.00
-943.00
483.23
444.52
448.78
303.04
201.29
285.63
133.53
273.31
Changes in Working Capital
367.00
-143.00
379.58
80.29
278.33
-297.39
-402.76
-344.62
587.99
-266.99
Cash after chg. in Working capital
510.00
-170.00
666.13
224.49
85.96
-241.50
155.54
516.35
1,612.19
1,866.52
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-97.00
-117.00
-17.17
-41.17
-17.52
-27.97
-83.93
-161.39
-135.90
-334.12
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-201.00
1,470.00
-155.53
94.57
630.24
-686.64
-818.19
-206.63
-851.62
1,085.37
Net Fixed Assets
-416.00
-200.42
-499.84
-39.00
-45.55
-166.75
-368.17
-299.87
-283.99
174.15
Net Investments
0.00
0.27
0.00
-0.05
0.00
0.00
0.00
10.73
0.00
0.00
Others
215.00
1,670.15
344.31
133.62
675.79
-519.89
-450.02
82.51
-567.63
911.22
Cash from Financing Activity
-71.00
-1,171.00
-679.58
-776.45
-769.47
1,254.49
254.26
-75.65
-601.32
-2,245.75
Net Cash Inflow / Outflow
141.00
12.00
-186.15
-498.56
-70.79
298.38
-492.32
72.68
23.35
372.02
Opening Cash & Equivalents
232.00
219.00
397.34
897.24
963.64
662.98
1,158.69
1,101.65
1,050.01
689.66
Closing Cash & Equivalent
370.00
232.00
219.34
397.34
897.24
963.64
664.64
1,158.69
1,101.65
1,050.01

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
266.04
280.48
238.55
238.75
254.47
298.51
339.05
306.20
294.97
216.65
ROA
-3.71%
-3.93%
-0.57%
-2.79%
-7.93%
-2.69%
3.25%
6.09%
13.36%
25.78%
ROE
-7.77%
-9.92%
-1.64%
-7.94%
-21.81%
-6.42%
7.07%
12.49%
30.04%
102.78%
ROCE
-1.96%
-5.50%
1.32%
-0.56%
-5.47%
-0.31%
6.87%
11.25%
18.98%
43.10%
Fixed Asset Turnover
0.88
0.75
0.52
0.70
0.70
0.82
1.00
0.98
1.08
1.32
Receivable days
65.29
85.04
138.12
98.15
92.57
97.55
75.93
49.71
54.33
55.81
Inventory Days
55.76
58.60
82.83
73.51
91.03
100.47
87.00
81.88
77.43
63.29
Payable days
232.91
255.87
129.66
86.65
67.29
64.08
64.54
63.71
65.00
65.49
Cash Conversion Cycle
-111.86
-112.23
91.29
85.01
116.31
133.94
98.39
67.88
66.75
53.61
Total Debt/Equity
0.49
0.70
1.22
1.28
1.33
1.26
0.71
0.55
0.54
0.77
Interest Cover
-0.37
-1.28
0.29
-0.13
-1.51
-0.10
3.24
11.42
11.69
9.53

News Update:


  • Wockhardt joins hand with various partners to roll out products in US
    22nd Aug 2022, 16:45 PM

    It has engaged multiple USFDA approved manufacturing partners in the US market, after thorough due diligence

    Read More
  • Wockhardt initiates global Phase III clinical study of WCK 5222
    16th Aug 2022, 16:00 PM

    The company has completed the first site initiation visit for the study

    Read More
  • Wockhardt - Quarterly Results
    12th Aug 2022, 15:59 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.